Uterine cancer, also known as endometrial cancer, begins in the lining of the uterus (the endometrium). It is the most common gynaecological cancer in women, usually diagnosed after menopause but it can also affect younger women. Early detection often leads to better outcomes as many women experience warning symptoms such as abnormal vaginal bleeding.
Uterine cancer—also called cancer of the corpus uteri (often endometrial cancer)—is a notable cancer burden in the Philippines.
According to the IARC Global Cancer Observatory (GLOBOCAN 2022) Philippines fact sheet:
These figures highlight why timely consultation and appropriate specialist evaluation are important—especially when abnormal bleeding or other symptoms persist.
Unlike cervical cancer, there is no routine nationwide screening test for uterine cancer. Women at higher risk, such as those with Lynch syndrome or a strong family history, may benefit from regular check-ups and early evaluation if symptoms occur. Pelvic ultrasound and endometrial biopsy are key tools doctors use when abnormal bleeding is reported.
Cancer is confined to the uterus
Cancer has spread to the cervix
Cancer has spread beyond the uterus but remains in the pelvis
Cancer has spread to the bladder, bowel, or distant organs
Treatment depends on the type, stage, and overall health of the patient. Options may include:
At OncoCare Philippines, our multidisciplinary team brings together oncologists, gynaecologic surgeons, radiation specialists, radiologists, pathologists, oncology nurses, and counsellors, supported by allied health professionals in nutrition, fertility, physiotherapy, and psycho-oncology. Together, they deliver personalised treatment plans tailored to every patient’s needs.
